Trimetazidine Reduces Cardiac Fibrosis in Rats by Inhibiting NOX2-Mediated Endothelial-to-Mesenchymal Transition

PURPOSE: Endothelial-to-mesenchymal transition (EndMT) is an important mechanism underlying cardiac fibrosis. The anti-ischemic drug trimetazidine (TMZ) is reportedly useful in ventricular remodeling and associated with NADPH oxidase (NOX) 2. This study aimed to investigate the possible effect of TM...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xingxing, Xia, Xue, Dong, Tiancheng, Lin, Zhiwei, Du, Leilei, Zhou, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357386/
https://www.ncbi.nlm.nih.gov/pubmed/35946039
http://dx.doi.org/10.2147/DDDT.S360283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357386/
https://www.ncbi.nlm.nih.gov/pubmed/35946039
http://dx.doi.org/10.2147/DDDT.S360283

Ejemplares similares